Kiromic BioPharma, Inc. (KRBP)

Kiromic BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3	1	3	17	38	45
Market Cap Growth	16.16%	-67.65%	-83.10%	-54.22%	-14.46%	9.82%
Enterprise Value	13	13	12	-7	28	43
PE Ratio	-	-0.05	-0.08	-0.68	-1.99	-11.90
PB Ratio	-0.54	-0.10	-0.51	0.64	3.36	22.54
P/FCF Ratio	-0.17	-0.04	-0.10	-0.79	-5.03	-13.87
P/OCF Ratio	-0.17	-0.04	-0.12	-0.86	-6.23	-15.31
EV/EBITDA Ratio	-0.87	-0.67	-0.40	0.30	-1.50	-11.80
EV/EBIT Ratio	-0.76	-0.60	-0.38	0.29	-1.48	-11.52
EV/FCF Ratio	-0.60	-0.62	-0.41	0.33	-3.76	-13.27
Debt / Equity Ratio	-1.88	-1.70	-1.63	0.02	0.04	0
Debt / EBITDA Ratio	-0.85	-0.78	-0.32	-0.02	-0.02	-
Debt / FCF Ratio	-0.59	-0.73	-0.33	-0.02	-0.06	-
Quick Ratio	0.19	0.16	0.05	7.44	6.92	2.86
Current Ratio	0.29	0.22	0.13	7.94	7.32	3.03
Interest Coverage	4.77	10.77	-186.87	-2109.48	-5817.24	-164.68
Return on Equity (ROE)	302.23%	229.69%	661.18%	-93.90%	-169.01%	-189.51%
Return on Assets (ROA)	-172.61%	-172.15%	-319.04%	-83.48%	-149.68%	-141.38%
Return on Capital (ROIC)	-318.34%	-310.50%	-855.80%	-92.66%	-162.27%	-187.24%
Earnings Yield	-630.88%	-2193.79%	-1293.45%	-146.85%	-50.32%	-8.41%
FCF Yield	-666.40%	-2244.32%	-969.76%	-127.17%	-19.87%	-7.21%
Buyback Yield / Dilution	-49.46%	-101.57%	-43.07%	-153.41%	-16.14%	-9.82%
Total Shareholder Return	-49.46%	-101.57%	-43.07%	-153.41%	-16.14%	-9.82%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.